| Literature DB >> 27957158 |
Luca Segreti1, Andrea Di Cori1, Giulio Zucchelli1, Ezio Soldati1, Giovanni Coluccia1, Stefano Viani1, Luca Paperini1, Maria Grazia Bongiorni1.
Abstract
Sustained ventricular tachyarrhythmias represent a kind of complication shared by a number of clinical presentations of heart disease, sometimes leading to sudden cardiac death. Many efforts have been made in the fight against such a complication, mainly being represented by the implantable cardioverter defibrillator (ICD). In recent years, catheter ablation has grown as a means to effectively treat patients with sustained ventricular arrhythmias, in the contest of different cardiac substrates. Since carrying an ICD is associated with a potential risk deriving from its possible infective or malfunctioning complications, and given the current effectiveness of lead extraction procedures, it has been thought not to be unreasonable to ask ourselves about how to deal with ICD patients who have been successfully treated by means of ablation of their ventricular arrhythmias. To date, no control data have been published on transvenous lead extraction in the setting of VT ablation. In this paper we will review the current evidence about ICD therapy, catheter ablation of ventricular arrhythmias and lead extraction, trying to outline some considerations about how to face this new clinical issue.Entities:
Year: 2015 PMID: 27957158 PMCID: PMC4956357 DOI: 10.4022/jafib.1172
Source DB: PubMed Journal: J Atr Fibrillation ISSN: 1941-6911